Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis

Novartis

Status: Completed

Conditions: Atopic Dermatitis

Study type: Observational

Funder types: Industry

Identifiers

NCT00098150

Ext 1 to ASM981C202

Details and patient eligibility

About

This extension study is being conducted to collect post-treatment safety information on patients who previously participated in the core clinical trial.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Consenting patients who participated in the core clinical trial